Simplex Trading, LLC Liminal Bio Sciences Inc. Transaction History

Simplex Trading, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 04, 2022	SELL	$0.4 - $0.59 $240 - $354	-600 Reduced 89.02%	74 $0
Q2 2022 Aug 03, 2022	SELL	$0.44 - $0.97 $88 - $194	-200 Reduced 22.88%	674 $0
Q1 2022 May 02, 2022	BUY	$0.82 - $1.13 $167 - $230	204 Added 30.45%	874 $0
Q4 2021 Feb 23, 2022	SELL	$0.92 - $2.2 $1,848 - $4,419	-2,009 Reduced 74.99%	670 $0
Q2 2021 Aug 12, 2021	BUY	$3.75 - $5.17 $10,046 - $13,850	2,679 New	2,679 $10,000

234

Ticker LMNL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 31,042,600
Description
Liminal BioSciences Inc., a clinical-stage biopharmaceutical company, focuses on the development of novel small molecule drug therapeutics for inflammatory, fibrotic, and metabolic diseases in Canada and the United Kingdom. The company's lead product candidate is fezagepras (PBI-4050), which has been completed Phase I clinical trial for the trea...

Get notified when there are updates to the investment portfolio of Simplex Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Simplex Trading, LLC with notifications on news.